Showing results (171-180 of 183) with videos related to
Sort By:
Pageof 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2025
STX-721, a Covalent EGFR/HER2 Exon 20 Inhibitor, Utilizes Exon 20-Mutant Dynamic Protein States and Achieves Unique Mutant Selectivity Across Human Cancer ModelsRaymond A Pagliarini, Jack A Henderson, Benjamin C Milgram, et al.Journal of Substance Use and Addiction Treatment|March 6, 2026
Racial and ethnic differences in medications for opioid use disorder and overdose in 11 state Medicaid programs from 2016 to 2020Julie Donohue, Bill Wang, Lu Tang, et al.Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine releaseCaroline Junqueira, Ângela Crespo, Shahin Ranjbar, et al.Research Square|August 17, 2021
SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine releaseCaroline Junqueira, Ângela Crespo, Shahin Ranjbar, et al.Lancet (London, England)|September 29, 2009
Challenges in evaluating surgical innovationPatrick L Ergina, Jonathan A Cook, Jane M Blazeby, et al.Nature|April 6, 2022
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammationCaroline Junqueira, Ângela Crespo, Shahin Ranjbar, et al.Lancet (London, England)|September 29, 2009
Evaluation and stages of surgical innovationsJeffrey S Barkun, Jeffrey K Aronson, Liane S Feldman, et al.Vaccine|May 31, 2011
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populationsDan H Barouch, Sandra V Kik, Gerrit J Weverling, et al.Lancet (London, England)|September 29, 2009
No surgical innovation without evaluation: the IDEAL recommendationsPeter McCulloch, Douglas G Altman, W Bruce Campbell, et al.Plos One|March 20, 2012
A collaboratively-derived science-policy research agendaWilliam J Sutherland, Laura Bellingan, Jim R Bellingham, et al.Pageof 19